CN Stock MarketDetailed Quotes

000766 Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Watchlist
  • 15.99
  • +1.45+9.97%
Not Open Aug 30 15:00 CST
15.45BMarket Cap340.21P/E (TTM)

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
15.51%264.64M
11.40%244.56M
-47.32%177.45M
-34.27%181.01M
-17.86%229.11M
-15.05%219.53M
11.68%336.82M
-19.07%275.38M
-27.28%278.91M
-43.09%258.43M
Transactional financial assets
-2.51%113.22K
777.77%1.07M
716.68%1.05M
2.76%108.55K
-16.74%116.14K
-25.62%121.97K
-28.80%128.39K
--105.63K
--139.48K
--163.99K
Notes receivable and accounts receivable
14.35%500.31M
38.25%508.53M
17.26%502.11M
10.62%425.56M
5.63%437.53M
-13.85%367.82M
22.11%428.19M
9.10%384.7M
1.10%414.2M
-20.57%426.97M
-Notes receivable
192.05%2.89M
4.52%3.22M
23.61%5.29M
14.38%3.49M
78.23%989.66K
--3.09M
8,459.85%4.28M
--3.05M
--555.28K
----
-Accounts receivable
13.95%497.42M
38.54%505.3M
17.20%496.82M
10.59%422.06M
5.54%436.54M
-14.58%364.73M
20.91%423.91M
8.24%381.65M
0.97%413.64M
-20.57%426.97M
Other receivables (including interest and dividends)
-40.40%24.45M
4.74%48.02M
-2.63%34.81M
-49.77%26.49M
-35.50%41.03M
-16.36%45.85M
-23.91%35.75M
-25.04%52.74M
-24.62%63.61M
-48.60%54.82M
-Dividend receivable
----
----
----
----
----
----
----
----
--12.72M
----
-Other receivable
-40.40%24.45M
----
-2.63%34.81M
----
-19.37%41.03M
----
-23.91%35.75M
----
-39.70%50.89M
----
Advance payment
-30.60%8.72M
-4.60%11.12M
-41.39%8.03M
30.64%14.47M
-12.03%12.56M
-12.65%11.66M
106.52%13.71M
-7.20%11.08M
13.48%14.28M
21.26%13.35M
Inventories
3.18%390.23M
-4.24%385.05M
-3.20%369.17M
2.17%385.05M
2.81%378.22M
9.48%402.09M
-0.83%381.37M
-8.51%376.89M
-9.96%367.89M
-11.51%367.26M
Receivable financing
126.74%19.43M
-3.24%14.02M
-56.91%18.2M
15.04%16.17M
73.49%8.57M
-11.91%14.49M
-9.12%42.23M
-49.51%14.05M
-76.79%4.94M
-16.52%16.45M
Other current assets
47.69%242.94K
-41.60%93.14K
141.48%397.2K
-92.47%161.5K
-96.19%164.49K
-98.71%159.49K
-98.87%164.49K
-88.72%2.15M
-79.98%4.32M
-41.53%12.38M
Total current assets
9.11%1.21B
14.20%1.21B
-10.27%1.11B
-6.09%1.05B
-3.57%1.11B
-7.66%1.06B
7.53%1.24B
-9.47%1.12B
-14.41%1.15B
-26.54%1.15B
Non Current assets
Other equity investment
0.00%1.91B
0.00%1.91B
0.00%1.91B
0.00%1.91B
0.00%1.91B
0.00%1.91B
0.00%1.91B
0.00%1.91B
0.00%1.91B
0.00%1.91B
Other non-current financial assets
0.00%18.77M
0.00%18.77M
0.00%18.77M
0.00%18.77M
0.00%18.77M
0.00%18.77M
0.00%18.77M
0.16%18.77M
0.16%18.77M
0.16%18.77M
Long-term equity investment
-0.77%53.32M
-6.01%53M
-6.63%52.68M
9.32%57.46M
-1.56%53.73M
2.32%56.39M
0.71%56.43M
-4.75%52.56M
-4.76%54.58M
-2.74%55.11M
Fixed assets
-4.15%713.87M
----
-4.02%736.17M
----
-5.59%744.75M
----
-5.41%767.03M
----
-4.90%788.82M
----
Constru in process
-1.83%269.28M
----
0.21%267.94M
----
2.94%274.32M
----
3.18%267.39M
----
4.38%266.48M
----
Productive biological assets
2.19%17M
18.77%16.96M
20.70%16.93M
25.44%16.84M
26.72%16.63M
9.77%14.28M
9.84%14.03M
6.26%13.42M
4.35%13.13M
3.97%13.01M
Intangible assets
-7.12%193.25M
-6.85%197.72M
-6.90%201.67M
-6.60%205.71M
-7.40%208.06M
-7.32%212.27M
-7.19%216.61M
-7.03%220.26M
-6.90%224.68M
-7.04%229.04M
Development expenditure
13.06%184.85M
7.60%173.96M
7.54%172.18M
5.50%166.35M
5.64%163.49M
4.58%161.67M
5.09%160.11M
7.23%157.67M
5.87%154.77M
6.68%154.58M
Goodwill
0.00%1.9M
0.00%1.9M
0.00%1.9M
0.00%1.9M
0.00%1.9M
-0.38%1.9M
-0.38%1.9M
-0.38%1.9M
-0.38%1.9M
0.00%1.91M
Long deferred expense
53.29%1.05M
59.03%1.17M
64.10%1.28M
68.62%1.39M
-20.69%688.08K
-20.97%732.95K
-18.75%777.83K
-18.17%822.7K
-17.76%867.58K
-30.50%927.41K
Deferred tax assets
-12.63%13.08M
-17.83%12.53M
-7.43%13.6M
-12.52%14.99M
-13.76%14.97M
-24.26%15.25M
-24.03%14.69M
-16.87%17.14M
-20.28%17.36M
-57.67%20.13M
Usufruct assets
98.83%3.66M
20.85%4.25M
12.40%4.83M
-50.87%1.81M
-51.01%1.84M
-8.53%3.52M
9.44%4.3M
--3.68M
--3.76M
--3.84M
Other non current assets
-46.82%7.16M
-33.16%6.97M
-44.18%5.85M
-0.48%10.05M
58.08%13.46M
27.77%10.43M
95.18%10.47M
-1.85%10.1M
-1.57%8.51M
-11.20%8.16M
Total non current assets
-1.03%3.39B
-1.34%3.39B
-1.12%3.41B
-1.09%3.42B
-1.18%3.43B
-1.33%3.44B
-1.21%3.45B
-1.11%3.45B
-1.16%3.47B
1.28%3.49B
Total assets
1.44%4.6B
2.32%4.61B
-3.54%4.52B
-2.31%4.47B
-1.78%4.53B
-2.90%4.5B
0.96%4.69B
-3.29%4.57B
-4.82%4.62B
-7.42%4.63B
Liabilities
Current liabilities
Short term loan
80.38%234.71M
73.04%225.15M
419.77%130.16M
225.29%130.12M
225.29%130.12M
225.29%130.12M
-37.48%25.04M
-11.11%40M
-11.11%40M
-68.02%40M
Notes payable and accounts payable
-37.27%143.44M
-18.07%167.11M
-13.88%191M
38.33%225.4M
28.03%228.66M
25.17%203.98M
47.28%221.79M
0.10%162.94M
4.13%178.6M
-19.53%162.96M
-Notes payable
183.15%10.96M
22.90%7.1M
21.91%7.65M
65.32%8.27M
53.31%3.87M
200.88%5.78M
226.86%6.28M
1,329.48%5M
--2.52M
--1.92M
-Accounts payable
-41.07%132.48M
-19.27%160.01M
-14.92%183.35M
37.48%217.12M
27.67%224.79M
23.08%198.2M
44.96%215.51M
-2.76%157.94M
2.66%176.08M
-20.47%161.04M
Contract liabilities
-15.06%12.12M
-4.07%13.02M
-70.69%11.66M
103.65%20.08M
106.61%14.26M
40.86%13.58M
245.98%39.79M
-32.91%9.86M
-61.56%6.9M
-60.18%9.64M
Salaries payable
-11.21%15.98M
-3.27%16.92M
-24.21%17.05M
-5.15%17.75M
-5.56%17.99M
-8.12%17.49M
14.26%22.5M
-11.82%18.71M
12.78%19.06M
3.71%19.04M
Taxs payable
-46.34%8.61M
6.94%12.94M
-34.91%20.37M
-24.62%16.98M
-30.72%16.04M
-40.75%12.1M
56.83%31.3M
117.98%22.52M
95.66%23.15M
106.14%20.43M
Other payable (including interest and dividends)
100.62%219.15M
87.84%196.89M
52.77%188.21M
-10.14%100.21M
-20.72%109.24M
-36.38%104.82M
-22.78%123.2M
-31.19%111.52M
-35.30%137.78M
-37.05%164.77M
-Dividend payable
0.00%3.59M
0.00%3.59M
0.00%3.59M
0.00%3.59M
0.00%3.59M
0.00%3.59M
0.00%3.59M
0.00%3.59M
0.00%3.59M
0.00%3.59M
-Other payable
104.04%215.56M
----
54.35%184.62M
----
-21.27%105.65M
----
-23.31%119.61M
----
-35.91%134.19M
----
Non current liabilities due within one year
15,120.44%8.7M
--8.67M
-93.72%12.86M
-99.96%75.84K
-100.00%57.15K
----
-87.39%204.88M
-54.00%195.87M
972.80%1.78B
944.68%1.78B
Other current liabilities
-29.02%782.99K
-33.73%853.3K
-65.13%1.17M
102.52%1.4M
120.38%1.1M
83.47%1.29M
187.38%3.37M
-43.00%690.23K
-60.96%500.57K
-39.56%701.78K
Total current liabilities
24.35%643.48M
32.73%641.57M
-14.79%572.49M
-8.91%512M
-76.31%517.48M
-78.05%483.38M
-66.86%671.86M
-33.33%562.11M
239.58%2.18B
170.57%2.2B
Current liabilities
Long term loan
-0.40%1.56B
0.21%1.57B
-0.40%1.56B
-0.78%1.56B
--1.56B
--1.56B
750.91%1.56B
6.74%1.58B
----
----
Deferred tax liabilities
7.57%3.87M
-2.80%4.14M
-11.72%4.36M
-26.60%3.97M
-41.14%3.59M
-37.39%4.26M
-32.38%4.94M
-28.80%5.41M
-24.91%6.11M
-22.24%6.8M
Long term deferred income
-8.96%62.22M
-10.09%63.01M
-9.85%64.75M
-9.60%66.6M
-9.38%68.34M
-9.07%70.08M
-8.96%71.83M
-8.64%73.67M
-8.98%75.41M
-8.03%77.08M
Lease liabilities
-9.03%2.16M
-47.00%2.14M
-51.76%2.14M
-41.75%2.32M
-39.67%2.37M
-5.02%4.03M
11.51%4.44M
--3.98M
--3.93M
--4.25M
Total non current liabilities
-0.75%1.63B
-0.35%1.64B
-0.98%1.63B
-1.35%1.64B
1,816.67%1.64B
1,763.23%1.64B
500.43%1.64B
6.03%1.66B
-95.45%85.45M
-95.32%88.12M
Total liabilities
5.28%2.27B
7.17%2.28B
-4.99%2.2B
-3.27%2.15B
-5.04%2.16B
-7.19%2.13B
0.66%2.32B
-7.75%2.22B
-10.02%2.27B
-15.10%2.29B
Shareholders equity
Paid-in capital
0.00%966.49M
0.00%966.49M
0.00%966.49M
0.00%966.49M
0.00%966.49M
0.00%966.49M
0.00%966.49M
0.00%966.49M
0.00%966.49M
0.00%966.49M
Capital reserve funds
-1.73%3.58B
-1.73%3.58B
-1.73%3.58B
-0.96%3.61B
0.00%3.64B
0.00%3.64B
0.00%3.64B
0.00%3.64B
0.00%3.64B
0.00%3.64B
Surplus reserve funds
0.00%108.65M
0.00%108.65M
0.00%108.65M
0.00%108.65M
0.00%108.65M
0.00%108.65M
0.00%108.65M
0.00%108.65M
0.00%108.65M
0.00%108.65M
Retained profit
1.93%-2.32B
1.94%-2.33B
1.85%-2.34B
1.39%-2.37B
1.39%-2.37B
1.30%-2.37B
1.25%-2.38B
1.31%-2.4B
0.82%-2.4B
1.51%-2.41B
Shareholders equity without minority interests
-0.75%2.33B
-0.72%2.33B
-0.82%2.32B
-0.08%2.32B
1.44%2.35B
1.35%2.34B
1.31%2.34B
1.40%2.32B
0.86%2.31B
1.63%2.31B
Minority interests
-98.89%347.33K
-98.59%443.77K
-98.53%464.26K
-98.51%473.31K
-3.05%31.17M
-3.08%31.4M
-2.95%31.64M
-3.03%31.87M
-3.21%32.15M
-3.43%32.4M
Total shareholder equity
-2.03%2.33B
-2.02%2.33B
-2.13%2.32B
-1.41%2.32B
1.38%2.38B
1.29%2.38B
1.25%2.37B
1.33%2.35B
0.81%2.35B
1.55%2.34B
Total liabilityies and equity
1.44%4.6B
2.32%4.61B
-3.54%4.52B
-2.31%4.47B
-1.78%4.53B
-2.90%4.5B
0.96%4.69B
-3.29%4.57B
-4.82%4.62B
-7.42%4.63B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Zhongzhu Certified Public Accountants (Special General Partnership)
--
--
--
Zhongzhu Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 15.51%264.64M11.40%244.56M-47.32%177.45M-34.27%181.01M-17.86%229.11M-15.05%219.53M11.68%336.82M-19.07%275.38M-27.28%278.91M-43.09%258.43M
Transactional financial assets -2.51%113.22K777.77%1.07M716.68%1.05M2.76%108.55K-16.74%116.14K-25.62%121.97K-28.80%128.39K--105.63K--139.48K--163.99K
Notes receivable and accounts receivable 14.35%500.31M38.25%508.53M17.26%502.11M10.62%425.56M5.63%437.53M-13.85%367.82M22.11%428.19M9.10%384.7M1.10%414.2M-20.57%426.97M
-Notes receivable 192.05%2.89M4.52%3.22M23.61%5.29M14.38%3.49M78.23%989.66K--3.09M8,459.85%4.28M--3.05M--555.28K----
-Accounts receivable 13.95%497.42M38.54%505.3M17.20%496.82M10.59%422.06M5.54%436.54M-14.58%364.73M20.91%423.91M8.24%381.65M0.97%413.64M-20.57%426.97M
Other receivables (including interest and dividends) -40.40%24.45M4.74%48.02M-2.63%34.81M-49.77%26.49M-35.50%41.03M-16.36%45.85M-23.91%35.75M-25.04%52.74M-24.62%63.61M-48.60%54.82M
-Dividend receivable ----------------------------------12.72M----
-Other receivable -40.40%24.45M-----2.63%34.81M-----19.37%41.03M-----23.91%35.75M-----39.70%50.89M----
Advance payment -30.60%8.72M-4.60%11.12M-41.39%8.03M30.64%14.47M-12.03%12.56M-12.65%11.66M106.52%13.71M-7.20%11.08M13.48%14.28M21.26%13.35M
Inventories 3.18%390.23M-4.24%385.05M-3.20%369.17M2.17%385.05M2.81%378.22M9.48%402.09M-0.83%381.37M-8.51%376.89M-9.96%367.89M-11.51%367.26M
Receivable financing 126.74%19.43M-3.24%14.02M-56.91%18.2M15.04%16.17M73.49%8.57M-11.91%14.49M-9.12%42.23M-49.51%14.05M-76.79%4.94M-16.52%16.45M
Other current assets 47.69%242.94K-41.60%93.14K141.48%397.2K-92.47%161.5K-96.19%164.49K-98.71%159.49K-98.87%164.49K-88.72%2.15M-79.98%4.32M-41.53%12.38M
Total current assets 9.11%1.21B14.20%1.21B-10.27%1.11B-6.09%1.05B-3.57%1.11B-7.66%1.06B7.53%1.24B-9.47%1.12B-14.41%1.15B-26.54%1.15B
Non Current assets
Other equity investment 0.00%1.91B0.00%1.91B0.00%1.91B0.00%1.91B0.00%1.91B0.00%1.91B0.00%1.91B0.00%1.91B0.00%1.91B0.00%1.91B
Other non-current financial assets 0.00%18.77M0.00%18.77M0.00%18.77M0.00%18.77M0.00%18.77M0.00%18.77M0.00%18.77M0.16%18.77M0.16%18.77M0.16%18.77M
Long-term equity investment -0.77%53.32M-6.01%53M-6.63%52.68M9.32%57.46M-1.56%53.73M2.32%56.39M0.71%56.43M-4.75%52.56M-4.76%54.58M-2.74%55.11M
Fixed assets -4.15%713.87M-----4.02%736.17M-----5.59%744.75M-----5.41%767.03M-----4.90%788.82M----
Constru in process -1.83%269.28M----0.21%267.94M----2.94%274.32M----3.18%267.39M----4.38%266.48M----
Productive biological assets 2.19%17M18.77%16.96M20.70%16.93M25.44%16.84M26.72%16.63M9.77%14.28M9.84%14.03M6.26%13.42M4.35%13.13M3.97%13.01M
Intangible assets -7.12%193.25M-6.85%197.72M-6.90%201.67M-6.60%205.71M-7.40%208.06M-7.32%212.27M-7.19%216.61M-7.03%220.26M-6.90%224.68M-7.04%229.04M
Development expenditure 13.06%184.85M7.60%173.96M7.54%172.18M5.50%166.35M5.64%163.49M4.58%161.67M5.09%160.11M7.23%157.67M5.87%154.77M6.68%154.58M
Goodwill 0.00%1.9M0.00%1.9M0.00%1.9M0.00%1.9M0.00%1.9M-0.38%1.9M-0.38%1.9M-0.38%1.9M-0.38%1.9M0.00%1.91M
Long deferred expense 53.29%1.05M59.03%1.17M64.10%1.28M68.62%1.39M-20.69%688.08K-20.97%732.95K-18.75%777.83K-18.17%822.7K-17.76%867.58K-30.50%927.41K
Deferred tax assets -12.63%13.08M-17.83%12.53M-7.43%13.6M-12.52%14.99M-13.76%14.97M-24.26%15.25M-24.03%14.69M-16.87%17.14M-20.28%17.36M-57.67%20.13M
Usufruct assets 98.83%3.66M20.85%4.25M12.40%4.83M-50.87%1.81M-51.01%1.84M-8.53%3.52M9.44%4.3M--3.68M--3.76M--3.84M
Other non current assets -46.82%7.16M-33.16%6.97M-44.18%5.85M-0.48%10.05M58.08%13.46M27.77%10.43M95.18%10.47M-1.85%10.1M-1.57%8.51M-11.20%8.16M
Total non current assets -1.03%3.39B-1.34%3.39B-1.12%3.41B-1.09%3.42B-1.18%3.43B-1.33%3.44B-1.21%3.45B-1.11%3.45B-1.16%3.47B1.28%3.49B
Total assets 1.44%4.6B2.32%4.61B-3.54%4.52B-2.31%4.47B-1.78%4.53B-2.90%4.5B0.96%4.69B-3.29%4.57B-4.82%4.62B-7.42%4.63B
Liabilities
Current liabilities
Short term loan 80.38%234.71M73.04%225.15M419.77%130.16M225.29%130.12M225.29%130.12M225.29%130.12M-37.48%25.04M-11.11%40M-11.11%40M-68.02%40M
Notes payable and accounts payable -37.27%143.44M-18.07%167.11M-13.88%191M38.33%225.4M28.03%228.66M25.17%203.98M47.28%221.79M0.10%162.94M4.13%178.6M-19.53%162.96M
-Notes payable 183.15%10.96M22.90%7.1M21.91%7.65M65.32%8.27M53.31%3.87M200.88%5.78M226.86%6.28M1,329.48%5M--2.52M--1.92M
-Accounts payable -41.07%132.48M-19.27%160.01M-14.92%183.35M37.48%217.12M27.67%224.79M23.08%198.2M44.96%215.51M-2.76%157.94M2.66%176.08M-20.47%161.04M
Contract liabilities -15.06%12.12M-4.07%13.02M-70.69%11.66M103.65%20.08M106.61%14.26M40.86%13.58M245.98%39.79M-32.91%9.86M-61.56%6.9M-60.18%9.64M
Salaries payable -11.21%15.98M-3.27%16.92M-24.21%17.05M-5.15%17.75M-5.56%17.99M-8.12%17.49M14.26%22.5M-11.82%18.71M12.78%19.06M3.71%19.04M
Taxs payable -46.34%8.61M6.94%12.94M-34.91%20.37M-24.62%16.98M-30.72%16.04M-40.75%12.1M56.83%31.3M117.98%22.52M95.66%23.15M106.14%20.43M
Other payable (including interest and dividends) 100.62%219.15M87.84%196.89M52.77%188.21M-10.14%100.21M-20.72%109.24M-36.38%104.82M-22.78%123.2M-31.19%111.52M-35.30%137.78M-37.05%164.77M
-Dividend payable 0.00%3.59M0.00%3.59M0.00%3.59M0.00%3.59M0.00%3.59M0.00%3.59M0.00%3.59M0.00%3.59M0.00%3.59M0.00%3.59M
-Other payable 104.04%215.56M----54.35%184.62M-----21.27%105.65M-----23.31%119.61M-----35.91%134.19M----
Non current liabilities due within one year 15,120.44%8.7M--8.67M-93.72%12.86M-99.96%75.84K-100.00%57.15K-----87.39%204.88M-54.00%195.87M972.80%1.78B944.68%1.78B
Other current liabilities -29.02%782.99K-33.73%853.3K-65.13%1.17M102.52%1.4M120.38%1.1M83.47%1.29M187.38%3.37M-43.00%690.23K-60.96%500.57K-39.56%701.78K
Total current liabilities 24.35%643.48M32.73%641.57M-14.79%572.49M-8.91%512M-76.31%517.48M-78.05%483.38M-66.86%671.86M-33.33%562.11M239.58%2.18B170.57%2.2B
Current liabilities
Long term loan -0.40%1.56B0.21%1.57B-0.40%1.56B-0.78%1.56B--1.56B--1.56B750.91%1.56B6.74%1.58B--------
Deferred tax liabilities 7.57%3.87M-2.80%4.14M-11.72%4.36M-26.60%3.97M-41.14%3.59M-37.39%4.26M-32.38%4.94M-28.80%5.41M-24.91%6.11M-22.24%6.8M
Long term deferred income -8.96%62.22M-10.09%63.01M-9.85%64.75M-9.60%66.6M-9.38%68.34M-9.07%70.08M-8.96%71.83M-8.64%73.67M-8.98%75.41M-8.03%77.08M
Lease liabilities -9.03%2.16M-47.00%2.14M-51.76%2.14M-41.75%2.32M-39.67%2.37M-5.02%4.03M11.51%4.44M--3.98M--3.93M--4.25M
Total non current liabilities -0.75%1.63B-0.35%1.64B-0.98%1.63B-1.35%1.64B1,816.67%1.64B1,763.23%1.64B500.43%1.64B6.03%1.66B-95.45%85.45M-95.32%88.12M
Total liabilities 5.28%2.27B7.17%2.28B-4.99%2.2B-3.27%2.15B-5.04%2.16B-7.19%2.13B0.66%2.32B-7.75%2.22B-10.02%2.27B-15.10%2.29B
Shareholders equity
Paid-in capital 0.00%966.49M0.00%966.49M0.00%966.49M0.00%966.49M0.00%966.49M0.00%966.49M0.00%966.49M0.00%966.49M0.00%966.49M0.00%966.49M
Capital reserve funds -1.73%3.58B-1.73%3.58B-1.73%3.58B-0.96%3.61B0.00%3.64B0.00%3.64B0.00%3.64B0.00%3.64B0.00%3.64B0.00%3.64B
Surplus reserve funds 0.00%108.65M0.00%108.65M0.00%108.65M0.00%108.65M0.00%108.65M0.00%108.65M0.00%108.65M0.00%108.65M0.00%108.65M0.00%108.65M
Retained profit 1.93%-2.32B1.94%-2.33B1.85%-2.34B1.39%-2.37B1.39%-2.37B1.30%-2.37B1.25%-2.38B1.31%-2.4B0.82%-2.4B1.51%-2.41B
Shareholders equity without minority interests -0.75%2.33B-0.72%2.33B-0.82%2.32B-0.08%2.32B1.44%2.35B1.35%2.34B1.31%2.34B1.40%2.32B0.86%2.31B1.63%2.31B
Minority interests -98.89%347.33K-98.59%443.77K-98.53%464.26K-98.51%473.31K-3.05%31.17M-3.08%31.4M-2.95%31.64M-3.03%31.87M-3.21%32.15M-3.43%32.4M
Total shareholder equity -2.03%2.33B-2.02%2.33B-2.13%2.32B-1.41%2.32B1.38%2.38B1.29%2.38B1.25%2.37B1.33%2.35B0.81%2.35B1.55%2.34B
Total liabilityies and equity 1.44%4.6B2.32%4.61B-3.54%4.52B-2.31%4.47B-1.78%4.53B-2.90%4.5B0.96%4.69B-3.29%4.57B-4.82%4.62B-7.42%4.63B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Zhongzhu Certified Public Accountants (Special General Partnership)------Zhongzhu Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg